Peer reviewed proceedings:
Gespeichert in:
| Körperschaft: | |
|---|---|
| Format: | Tagungsbericht Buch |
| Sprache: | English |
| Veröffentlicht: |
Basingstoke
Stockton
1997
|
| Schriftenreihe: | Leukemia
Supplement ; 11,1 |
| Schlagworte: | |
| Beschreibung: | Einzelaufnahme eines Zeitschr.-Suppl. |
| Beschreibung: | 36 S. Ill., graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV011380476 | ||
| 003 | DE-604 | ||
| 005 | 20150204 | ||
| 007 | t | ||
| 008 | 970611s1997 ad|| |||| 10||| eng d | ||
| 035 | |a (OCoLC)1070748753 | ||
| 035 | |a (DE-599)BVBBV011380476 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-29T |a DE-20 |a DE-12 | ||
| 111 | 2 | |a Workshop on the Clinical Results with Decitabine (5-Aza-2'-Deoxycytidine) in Hematologic Malignancies |d 1996 |c Paris |j Verfasser |0 (DE-588)1302171-0 |4 aut | |
| 245 | 1 | 0 | |a Peer reviewed proceedings |c Workshop on the Clinical Results with Decitabine (5-Aza-2'-Deoxycytidine) in Hematologic Malignancies, Paris, France, 30 May 1996. Suppl. ed.: Hagop M. Kantarjian ... |
| 246 | 1 | 3 | |a Peer-reviewed proceedings |
| 264 | 1 | |a Basingstoke |b Stockton |c 1997 | |
| 300 | |a 36 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Leukemia : Supplement |v 11,1 | |
| 500 | |a Einzelaufnahme eines Zeitschr.-Suppl. | ||
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Hämatopoese |0 (DE-588)4113823-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Leukämie |0 (DE-588)4035487-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Hämoblastose |0 (DE-588)4130932-7 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1996 |z Paris |2 gnd-content | |
| 689 | 0 | 0 | |a Hämoblastose |0 (DE-588)4130932-7 |D s |
| 689 | 0 | 1 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Hämatopoese |0 (DE-588)4113823-5 |D s |
| 689 | 1 | 1 | |a Leukämie |0 (DE-588)4035487-8 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Kantarjian, Hagop |d 1952- |e Sonstige |0 (DE-588)138403872 |4 oth | |
| 830 | 0 | |a Leukemia |v Supplement ; 11,1 |w (DE-604)BV005294202 |9 11,1 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007648241 | ||
Datensatz im Suchindex
| _version_ | 1804125891162275840 |
|---|---|
| any_adam_object | |
| author_GND | (DE-588)138403872 |
| author_corporate | Workshop on the Clinical Results with Decitabine (5-Aza-2'-Deoxycytidine) in Hematologic Malignancies Paris |
| author_corporate_role | aut |
| author_facet | Workshop on the Clinical Results with Decitabine (5-Aza-2'-Deoxycytidine) in Hematologic Malignancies Paris |
| author_sort | Workshop on the Clinical Results with Decitabine (5-Aza-2'-Deoxycytidine) in Hematologic Malignancies Paris |
| building | Verbundindex |
| bvnumber | BV011380476 |
| ctrlnum | (OCoLC)1070748753 (DE-599)BVBBV011380476 |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01815nam a2200433 cb4500</leader><controlfield tag="001">BV011380476</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20150204 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">970611s1997 ad|| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1070748753</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011380476</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-29T</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-12</subfield></datafield><datafield tag="111" ind1="2" ind2=" "><subfield code="a">Workshop on the Clinical Results with Decitabine (5-Aza-2'-Deoxycytidine) in Hematologic Malignancies</subfield><subfield code="d">1996</subfield><subfield code="c">Paris</subfield><subfield code="j">Verfasser</subfield><subfield code="0">(DE-588)1302171-0</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Peer reviewed proceedings</subfield><subfield code="c">Workshop on the Clinical Results with Decitabine (5-Aza-2'-Deoxycytidine) in Hematologic Malignancies, Paris, France, 30 May 1996. Suppl. ed.: Hagop M. Kantarjian ...</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Peer-reviewed proceedings</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basingstoke</subfield><subfield code="b">Stockton</subfield><subfield code="c">1997</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">36 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Leukemia : Supplement</subfield><subfield code="v">11,1</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Einzelaufnahme eines Zeitschr.-Suppl.</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hämatopoese</subfield><subfield code="0">(DE-588)4113823-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Leukämie</subfield><subfield code="0">(DE-588)4035487-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hämoblastose</subfield><subfield code="0">(DE-588)4130932-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1996</subfield><subfield code="z">Paris</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Hämoblastose</subfield><subfield code="0">(DE-588)4130932-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Hämatopoese</subfield><subfield code="0">(DE-588)4113823-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Leukämie</subfield><subfield code="0">(DE-588)4035487-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kantarjian, Hagop</subfield><subfield code="d">1952-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)138403872</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Leukemia</subfield><subfield code="v">Supplement ; 11,1</subfield><subfield code="w">(DE-604)BV005294202</subfield><subfield code="9">11,1</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007648241</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1996 Paris gnd-content |
| genre_facet | Konferenzschrift 1996 Paris |
| id | DE-604.BV011380476 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:08:45Z |
| institution | BVB |
| institution_GND | (DE-588)1302171-0 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007648241 |
| oclc_num | 1070748753 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-29T DE-20 DE-12 |
| owner_facet | DE-19 DE-BY-UBM DE-29T DE-20 DE-12 |
| physical | 36 S. Ill., graph. Darst. |
| publishDate | 1997 |
| publishDateSearch | 1997 |
| publishDateSort | 1997 |
| publisher | Stockton |
| record_format | marc |
| series | Leukemia |
| series2 | Leukemia : Supplement |
| spelling | Workshop on the Clinical Results with Decitabine (5-Aza-2'-Deoxycytidine) in Hematologic Malignancies 1996 Paris Verfasser (DE-588)1302171-0 aut Peer reviewed proceedings Workshop on the Clinical Results with Decitabine (5-Aza-2'-Deoxycytidine) in Hematologic Malignancies, Paris, France, 30 May 1996. Suppl. ed.: Hagop M. Kantarjian ... Peer-reviewed proceedings Basingstoke Stockton 1997 36 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Leukemia : Supplement 11,1 Einzelaufnahme eines Zeitschr.-Suppl. Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Hämatopoese (DE-588)4113823-5 gnd rswk-swf Leukämie (DE-588)4035487-8 gnd rswk-swf Hämoblastose (DE-588)4130932-7 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1996 Paris gnd-content Hämoblastose (DE-588)4130932-7 s Pharmakotherapie (DE-588)4076066-2 s DE-604 Hämatopoese (DE-588)4113823-5 s Leukämie (DE-588)4035487-8 s Kantarjian, Hagop 1952- Sonstige (DE-588)138403872 oth Leukemia Supplement ; 11,1 (DE-604)BV005294202 11,1 |
| spellingShingle | Peer reviewed proceedings Leukemia Pharmakotherapie (DE-588)4076066-2 gnd Hämatopoese (DE-588)4113823-5 gnd Leukämie (DE-588)4035487-8 gnd Hämoblastose (DE-588)4130932-7 gnd |
| subject_GND | (DE-588)4076066-2 (DE-588)4113823-5 (DE-588)4035487-8 (DE-588)4130932-7 (DE-588)1071861417 |
| title | Peer reviewed proceedings |
| title_alt | Peer-reviewed proceedings |
| title_auth | Peer reviewed proceedings |
| title_exact_search | Peer reviewed proceedings |
| title_full | Peer reviewed proceedings Workshop on the Clinical Results with Decitabine (5-Aza-2'-Deoxycytidine) in Hematologic Malignancies, Paris, France, 30 May 1996. Suppl. ed.: Hagop M. Kantarjian ... |
| title_fullStr | Peer reviewed proceedings Workshop on the Clinical Results with Decitabine (5-Aza-2'-Deoxycytidine) in Hematologic Malignancies, Paris, France, 30 May 1996. Suppl. ed.: Hagop M. Kantarjian ... |
| title_full_unstemmed | Peer reviewed proceedings Workshop on the Clinical Results with Decitabine (5-Aza-2'-Deoxycytidine) in Hematologic Malignancies, Paris, France, 30 May 1996. Suppl. ed.: Hagop M. Kantarjian ... |
| title_short | Peer reviewed proceedings |
| title_sort | peer reviewed proceedings |
| topic | Pharmakotherapie (DE-588)4076066-2 gnd Hämatopoese (DE-588)4113823-5 gnd Leukämie (DE-588)4035487-8 gnd Hämoblastose (DE-588)4130932-7 gnd |
| topic_facet | Pharmakotherapie Hämatopoese Leukämie Hämoblastose Konferenzschrift 1996 Paris |
| volume_link | (DE-604)BV005294202 |
| work_keys_str_mv | AT workshopontheclinicalresultswithdecitabine5aza2deoxycytidineinhematologicmalignanciesparis peerreviewedproceedings AT kantarjianhagop peerreviewedproceedings |